Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Int. braz. j. urol ; 41(5): 911-919, Sept.-Oct. 2015. tab, graf
Article in English | LILACS | ID: lil-767039

ABSTRACT

ABSTRACT Purpose: To determine if patients with renal cell carcinoma (RCC) with levels III and IV tumor thrombi are receive any reduction in complication rate utilizing veno-venous bypass (VVB) over cardiopulmonary bypass (CPB) for high level (III/IV) inferior vena cava (IVC) tumor thrombectomy and concomitant radical nephrectomy. Materials and Methods: From May 1990 to August 2011, we reviewed 21 patients that had been treated for RCC with radical nephrectomy and concomitant IVC thrombectomy employing either CPB (n =16) or VVB (n=5). We retrospectively reviewed our study population for complication rates and perioperative characteristics. Results: Our results are reported using the validated Dindo-Clavien Classification system comparing the VVB and CPB cohorts. No significant difference was noted in minor complication rate (60.0% versus 68.7%, P=1.0), major complication rate (40.0% versus 31.3%, P=1.0), or overall complication rate (60.0% versus 62.5%, P=1.0) comparing VVB versus CPB. We also demonstrated a trend towards decreased time on bypass (P=0.09) in the VVB cohort. Conclusion: The use of VVB over CPB provides no decrease in minor, major, or overall complication rate. The use of VVB however, can be employed on an individualized basis with final decision on vascular bypass selection left to the discretion of the surgeon based on specifics of the individual case.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Carcinoma, Renal Cell/surgery , Cardiopulmonary Bypass/adverse effects , Kidney Neoplasms/surgery , Nephrectomy/adverse effects , Thrombectomy/adverse effects , Vena Cava, Inferior/surgery , Carcinoma, Renal Cell/pathology , Cardiopulmonary Bypass/methods , Intraoperative Complications , Kidney Neoplasms/pathology , Nephrectomy/methods , Perioperative Period , Postoperative Complications , Retrospective Studies , Statistics, Nonparametric , Treatment Outcome , Thrombectomy/methods
2.
Int. braz. j. urol ; 41(1): 147-154, jan-feb/2015. tab, graf
Article in English | LILACS | ID: lil-742869

ABSTRACT

Purpose To assess the oncologic and functional outcomes of salvage renal surgery following failed primary intervention for RCC. Materials and Methods We performed a retrospective review of patients who underwent surgery for suspected RCC during 2004-2012. We identified 839 patients, 13 of whom required salvage renal surgery. Demographic data was collected for all patients. Intraoperative and postoperative data included ischemic duration, blood loss and perioperative complications. Preoperative and postoperative assessments included abdominal CT or magnetic resonance imaging, chest CT and routine laboratory work. Estimated glomerular filtration rate (eGFR) was calculated according to the Modification of Diet in Renal Disease equation. Results The majority (85%) of the patients were male, with an average age of 64 years. Ten patients underwent salvage partial nephrectomy while 3 underwent salvage radical nephrectomy. Cryotherapy was the predominant primary failed treatment modality, with 31% of patients undergoing primary open surgery. Pre-operatively, three patients were projected to require permanent post-operative dialysis. In the remaining 10 patients, mean pre- and postoperative serum creatinine and eGFR levels were 1.35 mg/dL and 53.8 mL/min/1.73 m2 compared to 1.43 mg/dL and 46.6 mL/min/1.73 m2, respectively. Mean warm ischemia time in 10 patients was 17.4 min and for all patients, the mean blood loss was 647 mL. The predominant pathological stage was pT1a (8/13; 62%). Negative surgical margins were achieved in all cases. The mean follow-up was 32.9 months (3.5-88 months). Conclusion While salvage renal surgery can be challenging, it is feasible and has adequate surgical, functional and oncological outcomes. .


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Carcinoma, Renal Cell/surgery , Kidney Neoplasms/surgery , Salvage Therapy/methods , Carcinoma, Renal Cell/pathology , Carcinoma, Renal Cell/physiopathology , Creatinine/blood , Glomerular Filtration Rate , Intraoperative Complications , Kidney Neoplasms/pathology , Kidney Neoplasms/physiopathology , Neoplasm Recurrence, Local , Nephrectomy/methods , Perioperative Period , Postoperative Complications , Reoperation , Retrospective Studies , Treatment Outcome , Warm Ischemia
3.
Int. braz. j. urol ; 40(5): 637-643, 12/2014. tab
Article in English | LILACS | ID: lil-731137

ABSTRACT

Purpose To compare retrograde dye injection through an externalized ureteral catheter with direct needle injection of dye into proximal ureter for identification of unrecognized collecting system disruption and integrity of subsequent repair during open partial nephrectomy. Materials and Methods We retrospectively reviewed the records of 259 consecutive patients who underwent open partial nephrectomy. Externalized ureteral catheters were placed preoperatively in 110 patients (Group 1); needle injection of methylene blue directly into proximal ureter was used in 120 patients (Group 2). No assessment of the collecting system was performed in 29 patients (Group 3). We compared intraoperative parameters, tumor characteristics, collecting system entry and incidence of urine leaks among the three groups. Results The mean tumor diameter was 3.1cm in Group 1, 3.6cm in Group 2, and 3.8 cm in Group 3 (p = 0.04); mean EBL 320cc, 351 cc and 376cc (p = 0.5); mean operative time 193.5 minutes, 221 minutes and 290 minutes (p < 0.001). Collecting system entry was recognized in 63%, 76% and 38% of cases in Groups 1, 2 and 3 respectively. (p = 0.07). Postoperative urine leaks requiring some form of management occurred in 11 patients from group 1 and 6 from group 2. (p = 0.2). No patient in Group 3 developed a urinary leak. Conclusions Identification of unrecognized collecting system disruption as well as postoperative urine leak rate in patients undergoing partial nephrectomy were not influenced by the intraoperative technique of identifying unrecognized collecting system entry. Postoperative urine leaks are uncommon despite recognized collecting system disruption in the majority of patients. .


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Kidney Neoplasms/surgery , Nephrectomy/methods , Urinary Catheters , Urinary Catheterization/methods , Kidney Neoplasms/pathology , Needles , Nephrectomy/instrumentation , Operative Time , Retrospective Studies , Statistics, Nonparametric , Stents , Time Factors , Treatment Outcome , Tumor Burden , Urinary Fistula/etiology
4.
Int. braz. j. urol ; 36(5): 571-582, Sept.-Oct. 2010. ilus, tab
Article in English | LILACS | ID: lil-567897

ABSTRACT

PURPOSE: To determine if there are any differences in the zonal distribution and tumor volumes of familial and sporadic prostate cancers (PC) in men undergoing radical prostatectomy. MATERIAL AND METHODS: 839 patients underwent a radical prostatectomy in the absence of prior neoadjuvant therapy between 1987 and 1996. Telephone interviews were conducted to obtain an updated family history. A positive family history was defined as the diagnosis of PC in at least one first degree relative. Prostatectomy specimens were examined to determine the number of tumor foci, zonal origin of the dominant tumor focus, tumor volume of the largest cancer focus, total tumor volume, Gleason score and stage, and the surgical margin status. Results were stratified according to family history and ethnicity. RESULTS: We successfully contacted 437 patients (52 percent). Prostatectomy specimens from 55 patients were excluded from review due to a history of prior transurethral resection of the prostate (n = 26) or uncertain pathological stage (n = 29). Of the remaining 382 patients, 76 (20 percent) reported having a first-degree relative with PC. Statistical analysis revealed no significant differences in the pathologic variables between the two groups of patients with or without a family history of PC. CONCLUSIONS: Familial and sporadic PC share similar characteristics. No histopathological differences account for the increased positive predictive value of PC screening tests among patients with a family history of PC.


Subject(s)
Humans , Male , Prostatectomy/methods , Prostatic Neoplasms/pathology , Tumor Burden , Age Factors , Family Characteristics , Logistic Models , Neoplasm Staging , Prostatic Neoplasms/ethnology , Prostatic Neoplasms/genetics , Socioeconomic Factors , United States
SELECTION OF CITATIONS
SEARCH DETAIL